Vimarsana
Biggest News Aggregation in the World

Biomarker Solution Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomarker Solution Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomarker Solution Center Today - Breaking & Trending Today

Non-Invasive Approaches to NAFLD/NASH Drug Development, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Non-Invasive Approaches to NAFLD/NASH Drug Development, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) June 13, 2023 -- This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webinar, speakers will

Source: prweb.com
Time for Change in NASH: How Non-Invasive Biomarkers are Driving a Paradigm Shift in Clinical Trials and Clinical Care, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Time for Change in NASH: How Non-Invasive Biomarkers are Driving a Paradigm Shift in Clinical Trials and Clinical Care, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) October 12, 2022 -- Diagnosing and assessing the progression of nonalcoholic steatohepatitis (NASH) continue to be some of the most

Source: prweb.com
Discovery Life Sciences Appoints Chief Scientific Officer to Drive Company's Rapid Global Expansion of Biomarker Services - Vimarsana News

Discovery Life Sciences Appoints Chief Scientific Officer to Drive Company's Rapid Global Expansion of Biomarker Services

/PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, announced that Suso J. Platero, Ph.D., has joined the company...

Immuno-Oncology – Converting Cancer to a "Chronic Disease," Upcoming Webinar Hosted by Xtalks - Vimarsana News

Immuno-Oncology – Converting Cancer to a "Chronic Disease," Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) November 04, 2021 -- The treatment of a cancer patient with immunotherapies offers unparalleled innovation that harnesses the immune

Source: prweb.com